- Home
- TNGX vs USGOW Comparison
TNGX vs USGOW Comparison
Compare TNGX & USGOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- USGOW
- Stock Information
- Founded
- TNGX 2014
- USGOW N/A
- Country
- TNGX United States
- USGOW United States
- Employees
- TNGX N/A
- USGOW 6
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- USGOW Precious Metals
- Sector
- TNGX Health Care
- USGOW Basic Materials
- Exchange
- TNGX Nasdaq
- USGOW Nasdaq
- Market Cap
- TNGX 735.0M
- USGOW N/A
- IPO Year
- TNGX N/A
- USGOW 2023
- Fundamental
- Price
- TNGX $6.64
- USGOW $1.42
- Analyst Decision
- TNGX Strong Buy
- USGOW
- Analyst Count
- TNGX 8
- USGOW 0
- Target Price
- TNGX $15.14
- USGOW N/A
- AVG Volume (30 Days)
- TNGX 885.7K
- USGOW N/A
- Earning Date
- TNGX 11-06-2024
- USGOW N/A
- Dividend Yield
- TNGX N/A
- USGOW N/A
- EPS Growth
- TNGX N/A
- USGOW N/A
- EPS
- TNGX N/A
- USGOW N/A
- Revenue
- TNGX $42,509,000.00
- USGOW N/A
- Revenue This Year
- TNGX $18.15
- USGOW N/A
- Revenue Next Year
- TNGX N/A
- USGOW N/A
- P/E Ratio
- TNGX N/A
- USGOW N/A
- Revenue Growth
- TNGX 26.16
- USGOW N/A
- 52 Week Low
- TNGX $6.33
- USGOW N/A
- 52 Week High
- TNGX $13.01
- USGOW N/A
- Technical
- Relative Strength Index (RSI)
- TNGX 37.15
- USGOW N/A
- Support Level
- TNGX $6.83
- USGOW N/A
- Resistance Level
- TNGX $7.47
- USGOW N/A
- Average True Range (ATR)
- TNGX 0.37
- USGOW 0.00
- MACD
- TNGX 0.11
- USGOW 0.00
- Stochastic Oscillator
- TNGX 27.31
- USGOW 0.00
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About USGOW U.S. GoldMining Inc. Warrant
US Goldmining Inc is a mineral exploration and development company. It is focused on the exploration and development of a project located in Alaska, USA. The company's sole property is Whistler Project which is a gold-copper exploration project located in the Yentna Mining District, approximately 170 km northwest of Anchorage, Alaska.